What highlights the role of CUL3 in cardiovascular disease is the identification of dominant-negative CUL3 mutations in patients with severe forms of familial hyperkalemic hypertension (FHHt) [94,95]. This evidence concerns the gene CUL3 and pseudohypoaldosteronism type 2.